Bender Robert & Associates
ABBV icon

Bender Robert & Associates’s AbbVie ABBV Stock Holding History

Bender Robert & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,466
Closed -$1.28M – 41
2024
Q2 		$1.28M Buy
+7,466
New +$1.24M 0.28% 27

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Bender Robert & Associates's ABBV Position: Q3 2026 in Review

Bender Robert & Associates increased its AbbVie (ABBV) stake by 36% in Q3 2026, buying an estimated $220K and bringing the position to 3,251 shares worth $850K. The position accounts for 0.16% of the portfolio, ranked #29.

Bender Robert & Associates first reported a position in ABBV in Q2 2015 and has held it in 45 quarters since. The position peaked at $5.61M in Q4 2017. 1,954 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Bender Robert & Associates held 3,251 shares of AbbVie worth $850K as of Q3 2026.
  • Bender Robert & Associates bought 858 AbbVie shares in Q3 2026, an estimated $220K.
  • AbbVie made up 0.16% of Bender Robert & Associates's portfolio in Q3 2026, its #29 holding.
  • Bender Robert & Associates first reported a position in AbbVie in Q2 2015 and has held it in 45 quarters since.
  • Bender Robert & Associates's AbbVie position peaked at $5.61M in Q4 2017.
  • 1,954 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Bender Robert & Associates's 13F filing for Q3 2026, filed 21 Oct 2026.